Monitor the company's response to Nasdaq by May 8, 2026. Failure to cure deficiencies could lead to immediate trading suspension and loss of exchange listing. Expect continued volatility and downside risk given the low public float and prior negative price reactions to similar events.
Price Chart
Executive Summary
Jaguar Health received a Nasdaq delisting notice on May 1, 2026, due to insufficient publicly held shares (~401,226 vs. 500k minimum) following a 1-for-35 reverse stock split. The company must respond to the Nasdaq Hearings Panel by May 8, 2026, but faces a high risk of delisting given multiple deficiencies, including the ongoing bid price non-compliance.
Key Facts
- Received Nasdaq delisting notice on May 1, 2026
- Publicly held shares post reverse split: ~401,226, below 500,000 minimum
- Also non-compliant with minimum $1 bid price requirement
- Must submit written response to Nasdaq Hearings Panel by May 8, 2026
- No assurance of regaining compliance; delisting would severely reduce liquidity
Financial Impact
Market cap of $3M at risk; delisting would likely force stock to OTC markets, severely impairing liquidity and institutional ownership.
Risk Factors
- Loss of Nasdaq listing and transfer to OTC markets
- Inability to regain compliance with public float or bid price requirements
- Potential trading suspension and further share price decline
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-202614 |
| Document: 0001193125-26-202614-index-headers.html | 0001193125-26-202614 |
| Document: 0001193125-26-202614-index.html | 0001193125-26-202614 |
| Document: 0001193125-26-202614.txt | 0001193125-26-202614 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | S-3 | $2.04 | awaiting T+60 | — | $2.19 (−7.36%) |
Oct 8, 2026 18d ago | DEF 14A | $4.79 | awaiting T+60 | — | $2.19 (+54.28%) |
Oct 5, 2026 22d ago | 8-K | $4.73 | awaiting T+60 | — | $2.19 (+53.70%) |
Sep 28, 2026 29d ago | 8-K | $6.02 | awaiting T+60 | — | $2.19 (+63.62%) |
Sep 24, 2026 4w ago | SC 13G/A | $7.70 | awaiting T+60 | — | $2.19 (+71.56%) |
Sep 24, 2026 4w ago | 424B5 | $7.06 | awaiting T+60 | — | $2.19 (+68.98%) |
Sep 24, 2026 4w ago | 8-K | $7.06 | awaiting T+60 | — | $2.19 (+68.98%) |
Sep 21, 2026 5w ago | 8-K | $34.46 | awaiting T+60 | — | $2.19 (−93.64%) |
Sep 15, 2026 5w ago | 8-K | $0.2246 | awaiting T+60 | — | $2.19 (−875.11%) |
Sep 3, 2026 7w ago | 424B5 | $10.41 | awaiting T+60 | — | $2.19 (+78.96%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers